首页> 美国卫生研究院文献>Protein Science : A Publication of the Protein Society >Lock and chop: A novel method for the generation of a PICK1 PDZ domain and piperidine‐based inhibitor co‐crystal structure
【2h】

Lock and chop: A novel method for the generation of a PICK1 PDZ domain and piperidine‐based inhibitor co‐crystal structure

机译:锁定和斩波:一种生成PICK1 PDZ域和基于哌啶的抑制剂共晶体结构的新方法

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The membrane protein interacting with kinase C1 (PICK1) plays a trafficking role in the internalization of neuron receptors such as the amino‐3‐hydroxyl‐5‐methyl‐4‐isoxazole‐propionate (AMPA) receptor. Reduction of surface AMPA type receptors on neurons reduces synaptic communication leading to cognitive impairment in progressive neurodegenerative diseases such as Alzheimer disease. The internalization of AMPA receptors is mediated by the PDZ domain of PICK1 which binds to the GluA2 subunit of AMPA receptors and targets the receptor for internalization through endocytosis, reducing synaptic communication. We planned to block the PICK1‐GluA2 protein–protein interaction with a small molecule inhibitor to stabilize surface AMPA receptors as a therapeutic possibility for neurodegenerative diseases. Using a fluorescence polarization assay, we identified compound BIO124 as a modest inhibitor of the PICK1‐GluA2 interaction. We further tried to improve the binding affinity of BIO124 using structure‐aided drug design but were unsuccessful in producing a co‐crystal structure using previously reported crystallography methods for PICK1. Here, we present a novel method through which we generated a co‐crystal structure of the PDZ domain of PICK1 bound to BIO124.
机译:与激酶C1(PICK1)相互作用的膜蛋白在神经元受体的内在化过程中起着运输作用,例如氨基3-羟基-5-5甲基-4-异恶唑丙酸酯(AMPA)受体。减少神经元上的表面AMPA型受体会减少突触通讯,从而导致进行性神经退行性疾病(例如阿尔茨海默氏病)的认知障碍。 AMPA受体的内在化是由PICK1的PDZ域介导的,该域与AMPA受体的GluA2亚基结合,并通过内吞作用靶向受体进行内在化,从而减少突触通讯。我们计划用一种小分子抑制剂阻断PICK1-GluA2蛋白与蛋白的相互作用,以稳定表面AMPA受体,作为神经退行性疾病的治疗可能性。使用荧光偏振分析,我们确定了化合物BIO124是PICK1-GluA2相互作用的适度抑制剂。我们进一步尝试使用结构辅助药物设计来提高BIO124的结合亲和力,但使用先前报道的PICK1晶体学方法未能成功产生共晶体结构。在这里,我们提出了一种新颖的方法,通过该方法我们生成了与BIO124结合的PICK1的PDZ域的共晶体结构。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号